NO20033855L - Fremgangsmåte ved fremstilling av farmasöytiske tabletter inneholdende paroxetinhydrokloridanhydrat - Google Patents

Fremgangsmåte ved fremstilling av farmasöytiske tabletter inneholdende paroxetinhydrokloridanhydrat

Info

Publication number
NO20033855L
NO20033855L NO20033855A NO20033855A NO20033855L NO 20033855 L NO20033855 L NO 20033855L NO 20033855 A NO20033855 A NO 20033855A NO 20033855 A NO20033855 A NO 20033855A NO 20033855 L NO20033855 L NO 20033855L
Authority
NO
Norway
Prior art keywords
tablets containing
paroxetine hydrochloride
preparation
pharmaceutical tablets
hydrochloride anhydrate
Prior art date
Application number
NO20033855A
Other languages
English (en)
Other versions
NO20033855D0 (no
Inventor
Niels Christian Felumb
Kristian Lund Henriksen
Soeren Bols Pedersen
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of NO20033855L publication Critical patent/NO20033855L/no
Publication of NO20033855D0 publication Critical patent/NO20033855D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20033855A 2001-03-02 2003-09-01 Fremgangsmåte ved fremstilling av farmasöytiske tabletter inneholdende paroxetinhydrokloridanhydrat NO20033855D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
PCT/DK2002/000134 WO2002069969A1 (en) 2001-03-02 2002-03-01 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate

Publications (2)

Publication Number Publication Date
NO20033855L true NO20033855L (no) 2003-09-01
NO20033855D0 NO20033855D0 (no) 2003-09-01

Family

ID=8160333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033855A NO20033855D0 (no) 2001-03-02 2003-09-01 Fremgangsmåte ved fremstilling av farmasöytiske tabletter inneholdende paroxetinhydrokloridanhydrat

Country Status (11)

Country Link
US (1) US20040072912A1 (no)
EP (1) EP1363633B1 (no)
AT (1) ATE294580T1 (no)
AU (1) AU2002233182B2 (no)
CA (1) CA2439460A1 (no)
DE (1) DE60203997T2 (no)
DK (2) DK200100341A (no)
ES (1) ES2239707T3 (no)
NO (1) NO20033855D0 (no)
PT (1) PT1363633E (no)
WO (1) WO2002069969A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162666A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US20040208932A1 (en) * 2003-04-17 2004-10-21 Ramachandran Thembalath Stabilized paroxetine hydrochloride formulation
WO2005034954A2 (en) * 2003-10-08 2005-04-21 Ranbaxy Laboratories Limited Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation
EP1841730A4 (en) * 2005-01-19 2010-10-27 Merck Frosst Canada Ltd CATHEPSIN K INHIBITORS AND ATHEROSCLEROSIS
WO2007015270A2 (en) * 2005-08-02 2007-02-08 Lupin Limited Novel controlled release compositions of selective serotonin reuptake inhibitors
CN113350350A (zh) * 2020-03-07 2021-09-07 齐鲁制药有限公司 一种含有盐酸培唑帕尼的药物组合物的制备方法
CN113730369B (zh) * 2020-05-27 2023-07-14 石药集团欧意药业有限公司 一种阿哌沙班片剂组合物及其制备方法
EP4586998A1 (en) * 2022-10-28 2025-07-23 Roquette Freres Compound for formulating moisture sensitive active ingredients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3471367D1 (en) * 1983-12-19 1988-06-23 Duphar Int Res Method of drying a solid and device therefor
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
EP1363633B1 (en) 2005-05-04
DK1363633T3 (da) 2005-05-30
PT1363633E (pt) 2005-09-30
DK200100341A (da) 2002-09-03
CA2439460A1 (en) 2002-09-12
US20040072912A1 (en) 2004-04-15
DE60203997T2 (de) 2006-02-23
ES2239707T3 (es) 2005-10-01
DE60203997D1 (de) 2005-06-09
AU2002233182B2 (en) 2004-10-14
EP1363633A1 (en) 2003-11-26
ATE294580T1 (de) 2005-05-15
NO20033855D0 (no) 2003-09-01
WO2002069969A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
RU2000123156A (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
ATE261300T1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
DK1327440T3 (da) Orale præparater med gunstige nedbrydningsegenskaber
JP2009537478A5 (no)
EA200500405A1 (ru) Твёрдые фармацевтические лекарственные формы, включающие телмисартан
HRP20100399T1 (hr) Oralno dezintegrirajući pripravak olanzapina ili donepezila
WO2002012242A3 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
PL343771A1 (en) N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
RU2017133990A (ru) Фармацевтические лекарственные формы ингибитора тирозинкиназы брутона
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
DK1113787T3 (da) Agitationsuafhængige farmaceutiske multipelenhedsretardformuleringer og fremgangsmåde til deres fremstilling
RU2010109366A (ru) Способ стабилизации фенилэфрина
WO2003057150A3 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
DK1368006T3 (da) Hidtil ukendt formulering med modificeret frigivelse
NO20033855D0 (no) Fremgangsmåte ved fremstilling av farmasöytiske tabletter inneholdende paroxetinhydrokloridanhydrat
ATE441410T1 (de) Fenofibrattabletten
KR100801121B1 (ko) 만성 관절 류마티즘 치료제
HRP20020181B1 (hr) Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak
WO2005041876A3 (en) Spill resistant formulations containing clays
DK1157612T3 (da) Granulære vanddispergerbare forbindelser og fremgangsmåde til deres fremstilling
EA199900193A1 (ru) Грануляты, содержащие водорастворимое соединение и целлюлозу
RU2183119C1 (ru) Фармацевтическая композиция, обладающая спазмолитической активностью, способ ее получения
RU2003136045A (ru) Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления
EA200900249A1 (ru) Фармацевтическая композиция и способ ее получения
RU2286779C2 (ru) Лекарственная форма, обладающая диуретическим и антигипертензивным действием, и способ ее изготовления

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application